Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact Contact Barchart
Market:
Absci Corp (ABSI)
Absci Corp (ABSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Alerts
Watch
Help
Go To:
Absci Corporation (ABSI) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release Zacks - Wed May 3, 9:00AM CDT

Absci Corporation (ABSI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ABSI : 1.4700 (-1.34%)
VBIV : 0.6621 (+0.84%)
The Joint Corp. (JYNT) Misses Q4 Earnings Estimates Zacks - Thu Mar 9, 5:35PM CST

The Joint Corp. (JYNT) delivered earnings and revenue surprises of -42.86% and 1.36%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

JYNT : 9.69 (+1.36%)
ABSI : 1.4700 (-1.34%)
Kiniksa Pharmaceuticals, Ltd. (KNSA) Beats Q4 Earnings and Revenue Estimates Zacks - Tue Feb 28, 10:25AM CST

Kiniksa Pharmaceuticals, Ltd. (KNSA) delivered earnings and revenue surprises of 125% and 31.18%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the...

KNSA : 16.64 (-2.92%)
ABSI : 1.4700 (-1.34%)
Absci Corporation (ABSI) Reports Q3 Loss, Tops Revenue Estimates Zacks - Wed Nov 9, 2022

Absci Corporation (ABSI) delivered earnings and revenue surprises of -11.11% and 32.72%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

ABSI : 1.4700 (-1.34%)
SANG : 3.99 (+3.64%)
Cidara Therapeutics (CDTX) Q3 Earnings Miss Estimates Zacks - Thu Nov 3, 2022

Cidara Therapeutics (CDTX) delivered earnings and revenue surprises of -43.33% and 8.65%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

CDTX : 1.0200 (unch)
ABSI : 1.4700 (-1.34%)
Absci Reports Second Quarter 2022 Financial Results and Business Update Globe Newswire - Thu Aug 11, 2022

Exceeded annual Active Program guidance with ten programs signed year-to-date Executed strategic reorganization to extend cash runway into late-2025 ...

ABSI : 1.4700 (-1.34%)
5 Biotech Stocks Likely to Outpace Q2 Earnings Estimates Zacks - Tue Aug 9, 2022

Let us look at some drug/biotech stocks, ABSI, AXLA, FRLN, DICE and PLRX, which are poised to beat on second-quarter earnings.

AXLA : 10.35 (+7.81%)
PLRX : 15.01 (-5.83%)
FRLN : 3.95 (+4.50%)
ABSI : 1.4700 (-1.34%)
DICE : 47.55 (+0.06%)
CRISPR Therapeutics AG (CRSP) Reports Q2 Loss, Misses Revenue Estimates Zacks - Mon Aug 8, 2022

CRISPR Therapeutics AG (CRSP) delivered earnings and revenue surprises of -7.62% and 96.27%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

CRSP : 45.49 (-1.24%)
ABSI : 1.4700 (-1.34%)
Absci to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit Conference Globe Newswire - Mon Aug 1, 2022

VANCOUVER, Wash. and NEW YORK, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep...

ABSI : 1.4700 (-1.34%)
Absci to Participate in the SVB Securities CybeRx: Big Data, A.I. & Machine Learning in Healthcare Event Globe Newswire - Thu Jul 21, 2022

VANCOUVER, Wash. and NEW YORK, July 21, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep...

ABSI : 1.4700 (-1.34%)

Barchart Exclusives

Stocks Set to Open Lower as Investors Await Key U.S. Inflation Data and Fed Speak Barchart - 1 hour ago
December S&P 500 futures (ESZ23) are down -0.05%, and December Nasdaq 100 E-Mini futures (NQZ23) are down -0.12% this morning as the benchmark U.S. 10-year yield rose toward a 15-year high, while market participants looked ahead to the release of the Fed’s favorite inflation gauge as well as speeches from Fed officials. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot